9P CXCR6+PD-1- Tissue resident memory T cells are associated with poor prognosis in patients with metastatic colorectal cancer
Background: Clear cell renal cell carcinoma (ccRCC), accounting for 80% of renal cell carcinoma (RCC) cases, is a common and deadly urological cancer.Only a small proportion of ccRCC patients obtain durable benefits from immunotherapy.Therefore, exploring novel predictive biomarkers for immunotherapy would be beneficial in guiding personalized clinical management for ccRCC patients.
Authors
- Virginie Mougey (ORCID: https://orcid.org/0000-0002-2262-0572)
- Alexandre Doussot (ORCID: https://orcid.org/0000-0003-0543-1793)
- Eve Laloy (ORCID: https://orcid.org/0000-0001-9254-8791)
- Jean‐René Pallandre (ORCID: https://orcid.org/0000-0002-7039-3319)
- R. Loyon
- Antoine El Kaddissi (ORCID: https://orcid.org/0000-0002-4353-3945)
- A. Bouard
- Laurie Spehner (ORCID: https://orcid.org/0000-0002-4126-5553)
- Angélique Vienot (ORCID: https://orcid.org/0000-0002-0381-7601)
- Franck Monnien (ORCID: https://orcid.org/0000-0002-2799-3730)
- Zaher Lakkis (ORCID: https://orcid.org/0000-0002-2608-5896)
- Syrine Abdeljaoued (ORCID: https://orcid.org/0000-0002-2423-5328)
- Marie Kroemer (ORCID: https://orcid.org/0000-0001-9274-619X)
- Christophe Borg (ORCID: https://orcid.org/0000-0002-2167-1458)
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Université de Franche-Comté (FR)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100892
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00